These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8896650

  • 1. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity.
    Bagrov AY, Dmitrieva RI, Fedorova OV, Kazakov GP, Roukoyatkina NI, Shpen VM.
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):982-90. PubMed ID: 8896650
    [Abstract] [Full Text] [Related]

  • 2. Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs.
    Bagrov AY, Fedorova OV, Dmitrieva RI, French AW, Anderson DE.
    Cardiovasc Res; 1996 Feb; 31(2):296-305. PubMed ID: 8730407
    [Abstract] [Full Text] [Related]

  • 3. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA, Bagrov AY.
    J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
    [Abstract] [Full Text] [Related]

  • 4. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY, Fedorova OV.
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [Abstract] [Full Text] [Related]

  • 5. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
    Bagrov AY, Dmitrieva RI, Dorofeeva NA, Fedorova OV, Lopatin DA, Lakatta EG, Droy-Lefaix MT.
    J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
    [Abstract] [Full Text] [Related]

  • 6. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta.
    Fedorova OV, Agalakova NI, Morrell CH, Lakatta EG, Bagrov AY.
    Hypertension; 2006 Dec; 48(6):1160-8. PubMed ID: 17043158
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction.
    Bagrov AY, Fedorova OV, Dmitrieva RI, Howald WN, Hunter AP, Kuznetsova EA, Shpen VM.
    Hypertension; 1998 May; 31(5):1097-103. PubMed ID: 9576120
    [Abstract] [Full Text] [Related]

  • 8. Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta.
    Bagrov AY, Roukoyatkina NI, Pinaev AG, Dmitrieva RI, Fedorova OV.
    Eur J Pharmacol; 1995 Feb 14; 274(1-3):151-8. PubMed ID: 7768267
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
    Fedorova OV, Bagrov AY.
    Am J Hypertens; 1997 Aug 14; 10(8):929-35. PubMed ID: 9270089
    [Abstract] [Full Text] [Related]

  • 10. Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats.
    Fedorova OV, Anderson DE, Bagrov AY.
    Am J Hypertens; 1998 Jul 14; 11(7):796-802. PubMed ID: 9683040
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
    Kramer HJ, Krampitz G, Bäcker A, Michel H, Krampitz G, Meyer-Lehnert H.
    Am J Hypertens; 1995 Jul 14; 8(7):753-60. PubMed ID: 7546503
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Endogenous marinobufagenin-like immunoreactive factor and Na+, K+ ATPase inhibition during voluntary hypoventilation.
    Bagrov AY, Fedorova OV, Austin-Lane JL, Dmitrieva RI, Anderson DE.
    Hypertension; 1995 Nov 14; 26(5):781-8. PubMed ID: 7591018
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
    Schoner W, Scheiner-Bobis G.
    Semin Nephrol; 2005 Sep 14; 25(5):343-51. PubMed ID: 16139690
    [Abstract] [Full Text] [Related]

  • 19. Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells.
    Uddin MN, Horvat D, Glaser SS, Danchuk S, Mitchell BM, Sullivan DE, Morris CA, Puschett JB.
    Placenta; 2008 Mar 14; 29(3):266-73. PubMed ID: 18279954
    [Abstract] [Full Text] [Related]

  • 20. Involvement of protein kinase C in reduced relaxant responses to the NO/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A2-mimetic U46619.
    Pérez-Vizcaíno F, Villamor E, Duarte J, Tamargo J.
    Br J Pharmacol; 1997 Aug 14; 121(7):1323-33. PubMed ID: 9257910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.